These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 8709137

  • 1. 3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: orally active, binding selective CCK-A agonists.
    Willson TM, Henke BR, Momtahen TM, Myers PL, Sugg EE, Unwalla RJ, Croom DK, Dougherty RW, Grizzle MK, Johnson MF, Queen KL, Rimele TJ, Yingling JD, James MK.
    J Med Chem; 1996 Jul 19; 39(15):3030-4. PubMed ID: 8709137
    [Abstract] [Full Text] [Related]

  • 2. Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonists.
    Henke BR, Aquino CJ, Birkemo LS, Croom DK, Dougherty RW, Ervin GN, Grizzle MK, Hirst GC, James MK, Johnson MF, Queen KL, Sherrill RG, Sugg EE, Suh EM, Szewczyk JW, Unwalla RJ, Yingling J, Willson TM.
    J Med Chem; 1997 Aug 15; 40(17):2706-25. PubMed ID: 9276016
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Peptide/benzodiazepine hybrids as ligands of CCK(A) and CCK(B) receptors.
    Escherich A, Lutz J, Escrieut C, Fourmy D, van Neuren AS, Müller G, Schafferhans A, Klebe G, Moroder L.
    Biopolymers; 1997 Aug 15; 56(2):55-76. PubMed ID: 11592053
    [Abstract] [Full Text] [Related]

  • 7. [Effect of cholesterol in bile on cholecystokinin receptor in the gallbladder].
    Fu H, Wu W, Zou S, Huang M, Huang C, Xu Y.
    Zhonghua Wai Ke Za Zhi; 2002 Oct 15; 40(10):786-8. PubMed ID: 12487887
    [Abstract] [Full Text] [Related]

  • 8. 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A agonists that demonstrate oral activity as satiety agents.
    Henke BR, Willson TM, Sugg EE, Croom DK, Dougherty RW, Queen KL, Birkemo LS, Ervin GN, Grizzle MK, Johnson MF, James MK.
    J Med Chem; 1996 Jul 05; 39(14):2655-8. PubMed ID: 8709093
    [No Abstract] [Full Text] [Related]

  • 9. 1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonists.
    Sherrill RG, Berman JM, Birkemo L, Croom DK, Dezube M, Ervin GN, Grizzle MK, James MK, Johnson MF, Queen KL, Rimele TJ, Vanmiddlesworth F, Sugg EE.
    Bioorg Med Chem Lett; 2001 May 07; 11(9):1145-8. PubMed ID: 11354363
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. mu-Opiate receptor agonist loperamide blocks bethanechol-induced gallbladder contraction, despite higher cholecystokinin plasma levels in man.
    Otto B, Mawe GM, Riepl RL.
    Neurogastroenterol Motil; 2005 Oct 07; 17(5):761-6. PubMed ID: 16185316
    [Abstract] [Full Text] [Related]

  • 13. New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity.
    Makovec F, Chistè R, Bani M, Pacini MA, Setnikar I, Rovati LA.
    Arzneimittelforschung; 1985 Oct 07; 35(7):1048-51. PubMed ID: 4052139
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CCK-A- and CCK-B-like receptors in the gallbladder and stomach of the alligator (Alligator mississippiensis).
    Oliver AS, Vigna SR.
    Gen Comp Endocrinol; 1997 Jan 07; 105(1):91-101. PubMed ID: 9000471
    [Abstract] [Full Text] [Related]

  • 16. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
    Boteju LW, Nikiforovich GV, Haskell-Luevano C, Fang SN, Zalewska T, Stropova D, Yamamura HI, Hruby VJ.
    J Med Chem; 1996 Sep 27; 39(20):4120-4. PubMed ID: 8831778
    [Abstract] [Full Text] [Related]

  • 17. The basis for progesterone impairment of gallbladder contractility in male guinea pigs in vitro.
    Kiaii B, Xu QW, Shaffer EA.
    J Surg Res; 1998 Oct 27; 79(2):97-102. PubMed ID: 9758722
    [Abstract] [Full Text] [Related]

  • 18. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
    Bignon E, Bachy A, Boigegrain R, Brodin R, Cottineau M, Gully D, Herbert JM, Keane P, Labie C, Molimard JC, Olliero D, Oury-Donat F, Petereau C, Prabonnaud V, Rockstroh MP, Schaeffer P, Servant O, Thurneyssen O, Soubrié P, Pascal M, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 1999 May 27; 289(2):742-51. PubMed ID: 10215648
    [Abstract] [Full Text] [Related]

  • 19. Biochemical and pharmacological profiles of loxiglumide, a novel cholecystokinin-A receptor antagonist.
    Fukamizu Y, Nakajima T, Kimura K, Kanda H, Fujii M, Saito T, Kasai H.
    Arzneimittelforschung; 1998 Jan 27; 48(1):58-64. PubMed ID: 9522034
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.